The Accelerated Access Collaborative (AAC) through Small Business Research Initiative (SBRI) Healthcare has awarded over £11 million of funding to 21 new innovations in stroke, cardiovascular disease and respiratory disease. Cardiovascular disease is the single biggest condition where lives can be saved by the NHS over the next decade and respiratory disease is the third […]

Innovation has been central during the global COVID-19 pandemic in finding solutions to complex and urgent challenges. As a way of supporting innovation, the Accelerated Access Collaborative (AAC) and the Care Quality Commission (CQC) have worked in partnership with providers and stakeholders to develop a set of 6 evidence-based principles that are crucial for providers […]

Here are the board papers from the 4 March 2020: Agenda and minutes.

Here are the board papers from the 23 October meeting: Agenda, minutes, AAC delivery update, patient and public involvement in the AAC, advanced therapy medicinal products (ATMPs) and tumour agnostic/histology-independent products.

Here are the board papers from the 26 June meeting: Minutes, role of boosted Accelerated Access Collaborative, and measuring the impact of the Accelerated Access Collaborative.

3D heart modelling to rapidly diagnose coronary disease and an advanced blood test which can cut the time it takes to rule-out a heart attack by 75% are among a raft of technological innovations being introduced for patients across the NHS. New innovations have already reached 300,000 patients, and speaking at the Reform digital health […]

New improvements to the Accelerated Access Collaborative (AAC) will put the most promising medicines, diagnostic tools and digital services through the clinical development and regulatory approval process faster. View the full news story on the gov.uk website.